The first patient has been treated in a first-in-human clinical trial investigating the safety and efficacy of the CXLens system, a quantitative corneal cross-linking, or qCXL, technology for ...
Please provide your email address to receive an email when new articles are posted on . “It is a game changer in cross-linking in the sense that it is not cross-linking to stabilize. This is what we ...
(MASS APPEAL) – If you’ve been diagnosed with Keratoconus then Corneal Cross Linking might get you back to better eyesight. Mass Appeal’s Patrick Berry joined Dr. John P. Frangie, MD to learn more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results